Laura Florea

Mrs. Laura Florea

University of Medicine and Pharmacy Grigore T Popa iasi România, Iaşi, Romania
+1

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
LCLavinia Caba
Lavinia Caba
LFLaura Florea
Laura Florea
Cristina GugCristina Gug
Cristina Gug
DDDaniela Cristina Dimitriu
Daniela Cristina Dimitriu
EGEusebiu Vlad Gorduza
Eusebiu Vlad Gorduza
Circular RNA (circRNA) is a distinct class of non-coding RNA produced, in principle, using a back-splicing mechanism, conserved during evolution, with increased stability and a tissue-dependent expression. Circular RNA represents a functional molecule with roles in the regulation of transcription and splicing, microRNA sponge, and the modulation of protein–protein interaction. CircRNAs are involved in essential processes of life such as apoptosis, cell cycle, and proliferation. Due to the regulatory role (upregulation/downregulation) in pathogenic mechanisms of some diseases (including cancer), its potential roles as a biomarker or therapeutic target in these diseases were studied. This review focuses on the importance of circular RNA in cancer.

27 May 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MPMonica Panzaru
Monica Panzaru
LCLavinia Caba
Lavinia Caba
LFLaura Florea
Laura Florea
EBElena Emanuela Braha
Elena Emanuela Braha
EGEusebiu Vlad Gorduza
Eusebiu Vlad Gorduza
Epidermolysis bullosa is a heterogeneous group of rare genetic disorders characterized by mucocutaneous fragility and blister formation after minor friction or trauma. There are four major epidermolysis bullosa types based on the ultrastructural level of tissue cleavage: simplex, junctional, dystrophic, and Kindler epidermolysis bullosa. They are caused by mutations in genes that encode the proteins that are part of the hemidesmosomes and focal adhesion complex. Some of these disorders can be associated with extracutaneous manifestations, which are sometimes fatal. They are inherited in an autosomal recessive or autosomal dominant manner. This review is focused on the phenomena of heterogeneity (locus, allelic, mutational, and clinical) in epidermolysis bullosa, and on the correlation genotype–phenotype.

Verified
Journal Article
Open access
PDF file
DZDaniela Luminita Zob
Daniela Luminita Zob
IAIolanda Augustin
Iolanda Augustin
LCLavinia Caba
Lavinia Caba
MPMonica Panzaru
Monica Panzaru
SPSetalia Popa
Setalia Popa
EGEusebiu Vlad Gorduza
Eusebiu Vlad Gorduza
Melanoma is a common and aggressive tumor originating from melanocytes. The increasing incidence of cutaneous melanoma in recent last decades highlights the need for predictive biomarkers studies. Melanoma development is a complex process, involving the interplay of genetic, epigenetic, and environmental factors. Genetic aberrations include BRAF, NRAS, NF1, MAP2K1/MAP2K2, KIT, GNAQ, GNA11, CDKN2A, TERT mutations, and translocations of kinases. Epigenetic alterations involve microRNAs, non-coding RNAs, histones modifications, and abnormal DNA methylations. Genetic aberrations and epigenetic marks are important as biomarkers for the diagnosis, prognosis, and prediction of disease recurrence, and for therapeutic targets. This review summarizes our current knowledge of the genomic and epigenetic changes in melanoma and discusses the latest scientific information.

1 January 2014
Verified
Journal Article
Closed access
TTTraian Tăranu
Traian Tăranu
LFLaura Florea
Laura Florea
DPDumitru Păduraru
Dumitru Păduraru
SGStefan Octavian Georgescu
Stefan Octavian Georgescu
LFLaurian Lucian Frâncu
Laurian Lucian Frâncu
CSCristinel Ionel Stan
Cristinel Ionel Stan

5 August 2019 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
AHAnca Roxana Hirja
Anca Roxana Hirja
LVLuminita Voroneanu
Luminita Voroneanu
DSDimitrie Siriopol
Dimitrie Siriopol
INIonut Nistor
Ionut Nistor
SHSimona Hogas
Simona Hogas
ACAdrian Constantin Covic
Adrian Constantin Covic

Verified
Journal Article
Open access
PDF file
IBIoana Balinisteanu
Ioana Balinisteanu
LCLavinia Caba
Lavinia Caba
AFAndreea Florea
Andreea Florea
RProxana popescu
roxana popescu
LFLaura Florea
Laura Florea
Cristina PredaCristina Preda
Cristina Preda
Acromegaly is a rare endocrine disorder characterized by the excessive production of growth hormone (GH) in adulthood. Currently, it is understood that certain pituitary neuroendocrine tumors (PitNETs) exhibit a hereditary predisposition. These tumors’ genetic patterns fall into two categories: isolated and syndromic tumors. The isolated forms are characterized by molecular defects that predispose exclusively to PitNETs, including familial isolated pituitary adenomas (FIPAs) and sporadic genetic defects not characterized by hereditary predisposition. All the categories involve either germline or somatic mutations, or both, each associated with varying levels of penetrance and different phenotypes. This highlights the importance of genetic testing and the need for a more comprehensive view of the whole disease. Despite the availability of multiple treatment options, diagnosis often occurs after several years, and management is still difficult. Early detection and intervention are crucial for preventing complications and enhancing the quality of life for affected individuals. This review aims to elucidate the molecular, clinical, and histological characteristics of GH-secreting PitNETs, providing insights into their prevalence, treatment nuances, and the benefits of genetic testing for each type of genetic disorder associated with acromegaly.